Predicting survival of cancer patients by chromosomal copy number heterogeneity.

Tom Van Den BoschErik van DijkLouis VermeulenDaniël M Miedema

Published in: Molecular & cellular oncology (2021)

We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.

Keyphrases

copy number
mitochondrial dna
genome wide
end stage renal disease
dna methylation
ejection fraction
single cell
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes